`
`
`
`MANDELBAUM BARRETT, P.C.
`Steven I Adler, Esq.
`A Professional Corporation
`3 Becker Farm Road, Suite 105
`Roseland, NJ 07068
`Ph.: 973-736-4600; Fax: 973-736-4670
`Counsel for Plaintiff Christopher Ward
`
`
`
`
`
`CHRISTOPHER WARD,
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`
`Plaintiff,
`
`
`NEWARK VICINAGE
`
`
`
`
`Civil Action No.:
`
`COMPLAINT
`
`Defendants.
`
`
`v.
`
`
`
`AETNA INC. and AETNA LIFE INSURANCE
`COMPANY,
`
`
`
`
`
`
`
`
`Plaintiff Christopher Ward, residing at 536 Cokesbury Road, Annandale, New Jersey, by
`
`way of Complaint against Defendants Aetna Inc., and Aetna Life Insurance Company, alleges
`
`and says:
`
`JURISDICTION AND VENUE
`
`1. This action arises under the Employee Retirement Income Security Act of 1974
`
`(“ERISA”), 29 U.S.C. Sections 1132(1), (e), (f), and (g) as well as 28 U.S.C. Section 1331, as this
`
`action involves a federal question and a claim by Plaintiff for employee benefits under an employee
`
`benefit plan regulated and governed under ERISA.
`
`2. Venue is proper pursuant to the provisions of 29 U.S.C. Section §1132(e)(2) as a substantial
`
`part of the events that give rise to Plaintiff's claims arose in the District of New Jersey and because
`
`4862-3899-7514, v. 2
`
`
`
`Case 3:22-cv-00280 Document 1 Filed 01/21/22 Page 2 of 6 PageID: 2
`
`
`
`one or more of the breaches complained of in this complaint occurred in said District. Plaintiff
`
`resides, and was denied coverage of his medical benefits, in this district.
`
`PARTIES
`
`3. Plaintiff Christopher Ward (“Plaintiff” or “Ward”) is a resident of New Jersey and this
`
`judicial district, residing at 536 Cokesbury Road, Annandale, New Jersey 08801.
`
`4. Defendant Aetna, Inc. (“Aetna, Inc.”) is, upon information and belief, a Pennsylvania
`
`corporation with its’ principal place of business in Pennsylvania.
`
`5. Defendant Aetna Life Insurance Company(“ALIC”) (Aetna, Inc. and ALIC, together
`
`“Aetna”) is, upon information and belief, a Connecticut Company, with its’ principal place of
`
`business in Connecticut.
`
`
`6. Plaintiff is a 62-year-old male, who sought medical attention for a full body rash, presumed
`
`FACTS
`
`to be eczema.
`
`7. After two biopsies were taken on or about October 27, 2021, Plaintiff was diagnosed with
`
`stage III CTCL-MF (Mycosis Fungoides) (“MF”), a rare form of blood cancer also called
`
`cutaneous T-cell lymphoma.
`
`8. Symptoms of MF include weight loss, redness, itching, and an overall burning sensation
`
`of one’s skin.
`
`9. According to Plaintiff’s doctor at Columbia University, New York-Presbyterian Hospital,
`
`Ward has a “severely atypical epidermotropic and dermal based lymphocytic infiltrate including a
`
`lymphomatoid vascular reaction consistent with early plaque stage mycosis fungoides with
`
`interstitial granulomatous features.” See diagnosis attached hereto as Exhibit “A”.
`
`10. This diagnosis was based upon two biopsies, one taken from the left posterior neck and the
`
`other from the left upper arm. The biopsies show a significantly atypical lymphocytic infiltrate.
`
`4862-3899-7514, v. 2
`
`
`
`Case 3:22-cv-00280 Document 1 Filed 01/21/22 Page 3 of 6 PageID: 3
`
`
`
`11. Based upon reported studies for stage III MF, the median survival rate is only four to six
`
`years. According to an article entitled Review of the treatment of mycosis fungoides and Sezary
`
`syndrome, a copy of which is annexed hereto as Exhibit “B”, the five-year survival rate for
`
`someone diagnosed with cutaneous peripheral T-cell lymphoma is only sixteen percent (16%).
`
`12. To treat MF, Plaintiff was put on a chemotherapy regimen, which he is still undergoing.
`
`13. Plaintiff has an insurance policy with Aetna (the “Policy”) entitled Critical Illness Plus
`
`with Cancer with Recurrence, group policy number 802252, for which he, and/or his employer,
`
`has paid all of the premiums. A copy of Plaintiff’s Benefit Summary is attached hereto as Exhibit
`
`“C.”
`
`14. The Policy, underwritten by ALIC, provides a fixed dollar benefit for covered claims of up
`
`to $40,000.
`
`15. The Policy makes clear that an insured, such as Ward, with this type of invasive cancer has
`
`coverage under the Plan.
`
`16. The Policy indicates that Aetna “will pay the applicable Cancer Benefit when an insured
`
`person is diagnosed as having cancer (invasive) …” See Ex. C, p. 4.
`
`17. The Policy defines “cancer (invasive)” as “the presence of malignant cells or a tumor
`
`characterized by the uncontrolled and abnormal growth and spread of the invasive cells.”
`
`18. Here, the blood cancer diagnosis clearly meets this definition. Photographs enclosed
`
`herewith also demonstrate that this form of blood cancer has spread. See Exhibit “D” annexed
`
`hereto.
`
`19. Cancers that begin anywhere in the body’s lymphatic system are called lymphomas. If such
`
`lymphomas have the ability to spread, they are called malignant and are, therefore, covered under
`
`the Policy.
`
`4862-3899-7514, v. 2
`
`
`
`Case 3:22-cv-00280 Document 1 Filed 01/21/22 Page 4 of 6 PageID: 4
`
`
`
`20. Despite the lymphoma being covered under the Policy, Plaintiff received a notice from
`
`Aetna, dated November 9, 2021, informing him that his claim under the Policy was denied because
`
`it erroneously concluded he has skin cancer.
`
`21. The EOB, annexed hereto as Exhibit “E”, confirms Aetna’s error with regard to Plaintiff’s
`
`medical condition. It indicates “The skin cancer benefit is not payable based on our review of the
`
`information provided. Your diagnosis did not meet the criteria and/or definition stated in the Plan
`
`certification.” See Ex. E, p. 1.
`
`22. As stated above, Plaintiff does not have skin cancer; he has MF. In fact, Plaintiff’s
`
`diagnosis confirms that problems with his skin are a reaction to his MF. See Exhibit “A”.
`
`23. Plaintiff appealed from the denial of his claim because Plaintiff did not, and does not, have
`
`skin cancer but suffers from a rare form of deadly lymphoma.
`
`24. By letter, dated December 6, 2021, Plaintiff’s counsel submitted the appeal, explaining that
`
`Defendants erroneously concluded that Plaintiff has skin cancer, as opposed to MF. A copy of this
`
`submission is attached hereto as Exhibit “F”.
`
`25. On December 21, 2021, Defendants’ Complaint and Appeal Analyst, Deborah H, notified
`
`Plaintiff that Aetna denied his appeal, reiterating that Aetna (erroneously) continued to assert that
`
`Plaintiff has skin cancer. A copy of this letter is attached as Exhibit “G”.
`
`26. In Aetna’s denial letter, it wrote that “the skin cancer benefit is not payable. Based on our
`
`review of the information provided, your diagnosis did not meet the criteria and/or definition stated
`
`in the Critical Illness Plus with Cancer Certificate.” See Ex. G, p. 5.
`
`27. Aetna also confirmed in writing that Plaintiff exhausted his internal appeals and that his
`
`claim could be pursued in court.
`
`4862-3899-7514, v. 2
`
`
`
`Case 3:22-cv-00280 Document 1 Filed 01/21/22 Page 5 of 6 PageID: 5
`
`
`
`28. Aetna’s denial of Plaintiff’s claim, in breach of the Policy, was in bad faith as it knows, or
`
`clearly should know, that Plaintiff does not have skin cancer, but a covered claim of MF. This
`
`diagnosis was confirmed by Ward’s main doctor at Columbia Presbyterian Hospital and his
`
`diagnosis was supplied to Aetna on at least two occasions.
`
`29. Aetna’s intentional and willful denial of Ward’s covered claim has cause Ward significant
`
`emotional distress and mental anguish as he continues to undergo chemotherapy to deal with his
`
`MF.
`
`
`
`FIRST COUNT
`(ERISA)
`
`30. The allegations in the foregoing paragraphs of this Verified Complaint are incorporated
`
`herein by reference as if restated herein at length.
`
`31. Plaintiff’s Policy with Aetna is a Plan governed by ERISA.
`
`32. Plaintiff has a medical condition covered by the Policy and Aetna breached its obligations
`
`under the Policy by refusing to pay Plaintiff benefits.
`
`33. Under 29 U.S.C. § 1132(a)(1)(B), Plaintiff is authorized to enforce his rights under the
`
`Policy and to obtain other appropriate equitable relief with respect to ERISA benefits to which he
`
`is entitled.
`
`34. Pursuant to ERISA, Plaintiff is entitled to benefits under the Policy and equitable relief
`
`declaring and adjudging him entitled to said benefits.
`
`35. Plaintiff also is entitled to, inter alia, reasonable attorneys’ fees and costs under ERISA.
`
`36. Aetna’s denial of Ward’s claim was in bad faith, willful, wanton, malicious and/or in
`
`reckless disregard of Ward’s rights.
`
`4862-3899-7514, v. 2
`
`
`
`Case 3:22-cv-00280 Document 1 Filed 01/21/22 Page 6 of 6 PageID: 6
`
`
`
`WHEREFORE, Plaintiff Christopher Ward demands judgment against Defendants Aetna,
`
`Inc., and Aetna Life Insurance Company, jointly, severally and/or in the alternative, as follows:
`
`A. Damages;
`B. Punitive damages;
`C.
`Interest;
`D. Costs of suit;
`E. Reasonable Attorney’s fees;
`F. Equitable and/or declaratory relief requiring Defendants to provide all
`coverage under the referenced ERISA plan; and
`G. Such further relief as this Court deems just and equitable under the
`circumstances.
`
`
`
`
`
`DATED: January 21, 2022
`
`
`Mandelbaum Barrett P.C.
`Attorneys for Plaintiff, Christopher Ward
`
`By:
`/s/ Steven Adler, Esq.
` Steven Adler, Esq.
`
`
`
`
`
`
`
`
`
`4862-3899-7514, v. 2
`
`